SelectQuote, Inc. (NYSE:SLQT – Get Free Report)’s stock price reached a new 52-week low on Wednesday. The stock traded as low as $5.9001 and last traded at $6.5410, with a volume of 58,061 shares traded. The stock had previously closed at $6.51.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on SLQT shares. Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a research note on Friday. Wall Street Zen raised shares of SelectQuote to a “hold” rating in a research report on Saturday. Finally, Zacks Research raised SelectQuote from a “strong sell” rating to a “hold” rating in a report on Monday, October 26th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $60.00.
Read Our Latest Analysis on SLQT
SelectQuote Stock Down 0.3%
The company has a debt-to-equity ratio of 1.16, a current ratio of 7.48 and a quick ratio of 7.48. The firm’s 50-day moving average price is $8.18 and its 200 day moving average price is $14.38. The firm has a market capitalization of $1.16 billion, a price-to-earnings ratio of -216.67 and a beta of 2.01.
SelectQuote (NYSE:SLQT – Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported ($4.20) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($6.60) by $2.40. SelectQuote had a return on equity of 22.48% and a net margin of 4.61%. The firm had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. Sell-side analysts expect that SelectQuote, Inc. will post -0.25 EPS for the current year.
Insiders Place Their Bets
In other SelectQuote news, Director Raymond F. Weldon purchased 20,491 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average price of $9.80 per share, for a total transaction of $200,811.80. Following the completion of the purchase, the director owned 46,152 shares in the company, valued at $452,289.60. The trade was a 79.85% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO William Grant, III bought 3,980 shares of the company’s stock in a transaction dated Friday, November 6th. The stock was bought at an average cost of $10.20 per share, with a total value of $40,596.00. Following the transaction, the chief operating officer directly owned 173,404 shares in the company, valued at approximately $1,768,720.80. The trade was a 2.35% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 45,993 shares of company stock worth $446,895. 11.60% of the stock is owned by insiders.
Institutional Trading of SelectQuote
Several large investors have recently added to or reduced their stakes in the business. Cetera Investment Advisers acquired a new position in shares of SelectQuote during the third quarter valued at approximately $43,000. SMH Capital Advisors Inc. acquired a new stake in shares of SelectQuote during the third quarter valued at approximately $47,000. EP Wealth Advisors LLC acquired a new position in SelectQuote during the second quarter valued at $51,000. Persistent Asset Partners Ltd purchased a new position in shares of SelectQuote during the 2nd quarter valued at $57,000. Finally, State of Wyoming lifted its stake in SelectQuote by 103.4% in the first quarter. State of Wyoming now owns 95,382 shares of the company’s stock valued at $60,000 after acquiring an additional 48,483 shares during the last quarter. 34.59% of the stock is currently owned by institutional investors and hedge funds.
SelectQuote Company Profile
SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.
Further Reading
- Five stocks we like better than SelectQuote
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.
